These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38040159)

  • 1. Protein corona, influence on drug delivery system and its improvement strategy: A review.
    Guo F; Luo S; Wang L; Wang M; Wu F; Wang Y; Jiao Y; Du Y; Yang Q; Yang X; Yang G
    Int J Biol Macromol; 2024 Jan; 256(Pt 2):128513. PubMed ID: 38040159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system.
    Xiao W; Gao H
    Int J Pharm; 2018 Dec; 552(1-2):328-339. PubMed ID: 30308270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein corona: a new approach for nanomedicine design.
    Nguyen VH; Lee BJ
    Int J Nanomedicine; 2017; 12():3137-3151. PubMed ID: 28458536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review.
    Kopac T
    Int J Biol Macromol; 2021 Feb; 169():290-301. PubMed ID: 33340622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protein corona and its effects on nanoparticle-based drug delivery systems.
    Li H; Wang Y; Tang Q; Yin D; Tang C; He E; Zou L; Peng Q
    Acta Biomater; 2021 Jul; 129():57-72. PubMed ID: 34048973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
    Moraru C; Mincea M; Menghiu G; Ostafe V
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preformed albumin corona, a protective coating for nanoparticles based drug delivery system.
    Peng Q; Zhang S; Yang Q; Zhang T; Wei XQ; Jiang L; Zhang CL; Chen QM; Zhang ZR; Lin YF
    Biomaterials; 2013 Nov; 34(33):8521-30. PubMed ID: 23932500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of Protein Corona on Nanoparticle Affects Different Complement Activation Pathways Mediated by C1q.
    Ding T; Sun J
    Pharm Res; 2019 Dec; 37(1):10. PubMed ID: 31872347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Corona-Enabled Systemic Delivery and Targeting of Nanoparticles.
    Chen D; Ganesh S; Wang W; Amiji M
    AAPS J; 2020 Jun; 22(4):83. PubMed ID: 32495039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein corona and nanoparticles: how can we investigate on?
    Pederzoli F; Tosi G; Vandelli MA; Belletti D; Forni F; Ruozi B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28296346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
    Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
    Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering the protein corona: Strategies, effects, and future directions in nanoparticle therapeutics.
    Zhao T; Ren M; Shi J; Wang H; Bai J; Du W; Xiang B
    Biomed Pharmacother; 2024 Jun; 175():116627. PubMed ID: 38653112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
    Shang L; Nienhaus GU
    Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles Penetrate into the Multicellular Spheroid-on-Chip: Effect of Surface Charge, Protein Corona, and Exterior Flow.
    Huang K; Boerhan R; Liu C; Jiang G
    Mol Pharm; 2017 Dec; 14(12):4618-4627. PubMed ID: 29096441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy.
    Khan S; Sharifi M; Gleghorn JP; Babadaei MMN; Bloukh SH; Edis Z; Amin M; Bai Q; Ten Hagen TLM; Falahati M; Cho WC
    J Control Release; 2022 Aug; 348():127-147. PubMed ID: 35660636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A health concern regarding the protein corona, aggregation and disaggregation.
    Falahati M; Attar F; Sharifi M; Haertlé T; Berret JF; Khan RH; Saboury AA
    Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):971-991. PubMed ID: 30802594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
    Liu N; Tang M; Ding J
    Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Cellular Transduction of Nanoparticles Resistant to Rapidly Forming Plasma Protein Coronas.
    Blokpoel Ferreras LA; Scott D; Vazquez Reina S; Roach P; Torres TE; Goya GF; Shakesheff KM; Dixon JE
    Adv Biosyst; 2020 Oct; 4(10):e2000162. PubMed ID: 32924327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How protein coronas determine the fate of engineered nanoparticles in biological environment.
    Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
    Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.